ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 701

Vascular Differences Associated to Genetic Polymorphisms of Endothelial Nitric Oxide Synthase in Mexican Patients with Systemic Sclerosis. A Preliminary Report

Maria Pilar Cruz-Dominguez1, Maria Angeles Martinez-Godinez2, Angel Miliar-Garcia2, Daniel Hector Montes-Cortes3, Olga Vera-Lastra4, Luis J. Jara-Quezada5 and Anabel Reyes-Salazar6, 1Division of Research, Hospital de Especialidades Centro Medico Nacional La Raza., Mexico, DF, Mexico, 2Postgraduate Studies and Research Section, Escuela Superior de Medicina. IPN,, Mexico, D.F., Mexico, 3Investigación, Hospital General CMN La Raza, IMSS, Mexico DF, Mexico, 4Internal Medicine, MD, Mexico City, Mexico, 5Direction of Education and Research, Hospital de Especialidades Centro Médico La Raza, IMSS, Mexico City, Mexico, 6Angiology, Hospital de especialidades Centro Medico National “La Raza”, IMSS, Mexico, D.F., Mexico

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Doppler ultrasound, intima medial thickness, polymorphism and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud’s – Clinical Aspects and Therapeutics

Session Type: Abstract Submissions (ACR)

Background/Purpose: Vascular dysfunction usually is observed before clinically detectable fibrosis of systemic sclerosis (SSc). The eNOS catalyses the synthesis of nitric oxide (NO), which maintains basal vascular tone and endothelial function. Abnormal production of e-NOS and/or iNOS impairs NO availability causing vascular disease. Genetic polymorphism may participate in these alterations.   

Objective: To investigate vascular differences associated to polymorphisms T-786C and G894T of the eNOS gene on differential expression of eNOS/iNOS in the skin and vascular Duplex Sonography parameters of SSc patients.

Methods: We included 139 consecutive SSc patients. The genotyping of T-786C and G894T polymorphisms of eNOS gene was performed by Polymerase Chain Reaction Real-Time Assay. The control group included 180 age-matched healthy volunteers. For the eNOS/iNOS skin expression we included 31 patients (14 lcSSc and 17 dcSSc).

Results: In lcSSc: T-786C prevalence was TT65.5%, TC30.2% and CC4.3% (OR 1.8, IC 0.4-7.9 associated to SSc); and the G894T prevalence was GT74.3%, GT20.3% and TT5.4% (OR 1.94, IC 0.54-7.04 associated to SSc). In dcSSc: the T-786C prevalence was TT76.6%, TC20%, and CC3.3%, and G894T polymorphism was GT 82%, GT 18% and TT 0% without association with SSc. In control group: the prevalence of T-786C polymorphism was TT68.45%, TC29.4%, and CC2.22%; for G894T polymorphism was GG74.1%, GT23.02%, TT2.87%. The mean relative expression of eNOS was 10.17+/-15.5  and  iNOS of 7.6+/-13.05 in lcSSc. For dcSSc  the mean relative expression of eNOS  was 1.74+/-1.16  and iNOS of 2.1+/-2.5.  1.08+/-0.3 and 1.36+/-0.7 in skin of volunteers of control group. Left brachial intima-media thickness was statistically significantly greater in allelic variants of eNOS in SSc (p=0.025).

Conclusion: In the skin of both subtypes of systemic sclerosis, the relative expression of eNOS and iNOS is increased. Genetic polymorphisms of eNOS is associated with anormal  intima-media thicknes in SSc patients.


Disclosure:

M. P. Cruz-Dominguez,
None;

M. A. Martinez-Godinez,
None;

A. Miliar-Garcia,
None;

D. H. Montes-Cortes,
None;

O. Vera-Lastra,
None;

L. J. Jara-Quezada,
None;

A. Reyes-Salazar,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/vascular-differences-associated-to-genetic-polymorphisms-of-endothelial-nitric-oxide-synthase-in-mexican-patients-with-systemic-sclerosis-a-preliminary-report/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology